Illinois reported April sales figures for adult-use cannabis, revealing a minor sequential decline of 0.6%, totaling $146.6 million. On a per-day basis, however, sales increased by 3.8%. Year-over-year, sales grew by 1.4%, showing an improvement compared to the declines seen in February and March. Notably, the number of units sold rose by 9.0% from the previous year, indicating that consumers might be opting for lower-priced products or that prices are decreasing overall. Sequentially, units sold increased by 4.6%.
After experiencing notable growth in previous years—106% in 2021, 13% in 2022, and 5% in 2023—2024 has shown a year-to-date increase of 5.4%, bringing total adult-use sales to $1.72 billion. However, the current year, 2025, is seeing only a modest rise of 0.4% thus far.
In March, sales to non-residents accounted for 20.5% of the total. For the medical cannabis program, sales in April fell by 1.6% sequentially, amounting to $19.7 million and reflecting a 13.2% decrease year-over-year. Combined adult-use and medical cannabis sales in March reached $168.4 million, down 0.7% both from the previous month and compared to March of the previous year.
Total cannabis sales in 2024 reached $2.01 billion, marking a 2.5% increase from 2023. However, early 2025 figures indicate a 1.9% decline in sales compared to the first three months of 2024.
Alan Brochstein, founder of 420 Investor, an online community focused on cannabis stocks, emphasizes the importance of understanding these trends for industry stakeholders. With over two decades of experience in research and portfolio management before transitioning to the cannabis sector, Brochstein continues to connect industry players and promote sustainable growth. His insights are sought after in various media outlets, including the New York Times and Bloomberg TV.
English 
Spanish 
German 
Czech